Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest American Association for Cancer Research Stories

2013-04-10 16:05:38

Study of RNA interference drug presented at AACR Annual Meeting 2013 The safety and preliminary efficacy of a new class of tumor fighting drugs were reported today by Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute (TGen). Early results from the phase I, first in-human study of an RNA interference (RNAi) drug were announced during the American Association for Cancer Research (AACR) Annual Meeting 2013, April 6-10,...

2013-04-09 23:02:48

BerriProducts LLC shares new research in human colorectal cancer patients that bolsters the growing body of evidence supporting the cancer-preventive effects of black raspberries and suggests that eating black raspberries beneficially alters fat metabolism to reduce cancer risk. Portland, OR (PRWEB) April 09, 2013 A cancer prevention research team led by Li-Shu Wang, PhD, of the Medical College of Wisconsin, has revealed more information about the effects of black raspberry powder on fatty...

2013-04-07 12:20:14

NKTR-214 Demonstrates Improved Efficacy in Resistant Preclinical Melanoma Model Through Preferential Activation of Tumor Killing Immune Cell Subtype SAN FRANCISCO, April 7, 2013 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today presented positive preclinical data for NKTR-214, a novel cancer immunotherapy which targets the IL-2 receptor complex, at the 2013 American Association for Cancer Research (AACR) Annual Meeting. NKTR-214 is a new immunocytokine that is being developed...

2013-04-05 00:20:07

National Foundation for Cancer Research (NFCR) honours Professor Alex Matter with esteemed award for groundbreaking cancer pill that gives leukaemia patients a new lease of life.Singapore, Apr 5, 2013 - (ACN Newswire) - Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gyorgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development...

2013-04-04 08:28:34

Oncomine® Gene Browser: Cost-effective option for academic, biotech and smaller pharma researchers to search premier cancer genomics database for expression, copy number and mutation data CARLSBAD, Calif., April 4, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) announced today the introduction of two bioinformatics offerings - Oncomine(R) Gene Browser and Ion Reporter(TM) Oncomine(R) Workflow - that will allow cancer researchers new avenues of access to one...

No Side Effects With New Cancer Radiation Treatment
2013-04-03 18:51:30

Lee Rannals for redOrbit.com — Your Universe Online Scientists have developed a new form of radiation therapy that successfully put cancer into remission in mice. The new treatment did not produce any harmful side effects typically seen with conventional chemo and radiation cancer therapies. The team says clinical trials in humans could begin as soon as funding is secured. “Since the 1930s, scientists have sought success with a cancer treatment known as boron neutron...

2013-04-01 00:20:20

IGDRASOL will present updates on Cynviloq(TM), its late clinical stage paclitaxel nanoparticle formulation. Highlights include the therapeutic evaluation of Cynviloq(TM) in poorly perfused tumors as well as the potential development of Cynviloq(TM)-based personalized paclitaxel cancer therapy. SAN DIEGO and FOUNTAIN VALLEY, Calif., March 31, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. ("STI"; SRNE) and IGDRASOL announced today that IGDRASOL will be presenting updates of its...

2013-03-28 12:30:41

Dr. Brodie Best Known for Role in Developing Aromatase Inhibitors BALTIMORE, March 28, 2013 /PRNewswire-USNewswire/ -- Angela H. Brodie, Ph.D., a University of Maryland scientist whose research paved the way for a new class of drugs widely used to treat breast cancer patients around the world, has been selected by the American Association for Cancer Research (AACR) as a fellow of the newly created AACR Academy. Dr. Brodie, professor of pharmacology at the University of Maryland School...

Cancer Survivor Numbers On The Rise
2013-03-27 19:16:39

Peter Suciu for redOrbit.com — Your Universe Online While once considered a death sentence to many, cancer survival is on the rise. The increase is, in part, due to an aging population. But it is also thanks to advances in early detection and treatment. As a result, more people will survive cancer. On Wednesday, the American Association for Cancer Research reported the number of cancer survivors is expected to increase by 31 percent to 18 million by 2022. Currently there are some...

2013-03-11 15:10:32

A new immunoassay that tests for the presence of three biomarkers appears to be a valid screening method for the early detection of malignant kidney cancer, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. "Renal cell carcinoma, a malignant tumor arising from the kidney, is one of the most difficult forms of cancer to detect and treat properly because it remains silent until disseminating to other...